Israel
Overview
How does AGG bring value to our Israeli clients?
AGG provides comprehensive legal services tailored to the individual needs of our clients who have a focus in Israel. We leverage our deep understanding of the Israeli market and culture to offer strategic counsel across a variety of legal matters, including real estate, FDA (marketing authorization and regulatory compliance), global mobility, data privacy, financial investments, corporate matters, litigation & dispute resolution and intellectual property. By focusing on what truly matters, we bridge complex legal landscapes in order to achieve the client’s business goals in the U.S. and beyond. Our value lies in our ability not only to address immediate legal needs but also in our proactive approach in identifying opportunities for growth and connection.
What makes AGG distinctive from other law firms with an Israeli focus?
What sets us apart is our deep-rooted commitment to Israel and the close relationships we have cultivated over the last 20 years with law firms, consultants, investors, companies, and educators. We are not merely advisors; we connectors, bringing Israeli clients into the heart of global business networks. We maintain a robust presence in the Israeli market, reinforced by our active participation in international organizations, such as the International Bar Association. Our firm’s extensive involvement with key organizations such as AIPAC, AJFF, the American Jewish Committee, JNF, and ADL, along with our collaboration with Conexx (formerly, the Israel Atlanta Chamber of Commerce) and the southeastern regional office of Israeli Consul General from Israel, reflects our dedication to the Israeli community. Our distinctive approach is grounded in a combination of legal acumen, cultural understanding, and a passion for fostering strong business relationships between Israeli clients and their required resources throughout the world.
How do we assist Israeli Businesses?
An example of our work with Israeli clients involved assisting an Israeli medical device company in expanding its operations to the U.S. The client faced significant challenges with FDA regulatory compliance for a new medical device it was launching. AGG’s Food & Drug team provided critical guidance on navigating the complex approval process, ensuring the client met all regulatory requirements while maintaining its go-to-market timeline. Simultaneously, our team facilitated connections with Israeli investors and healthcare partners, helping the client secure the resources needed to successfully launch their product in the U.S. market.
Additionally, our Israel team has introduced numerous Israeli capital sources to real estate investments throughout the United States — relationships that have grown businesses and opportunities in the United States and in Israel.
“The AGG team remains committed to fostering connections between Israeli investors, companies, and law firms, and the U.S. business and legal community. With extensive experience and contacts in both Israel and the U.S., the AGG team plans to continue building bridges between these communities.”
– Atlanta Jewish Times
Experience
- Led and resolved a cross-border trademark infringement dispute in the life sciences space representing the interests of parties from Israel, the United Kingdom, and Canada against a U.S.-based party’s trademark infringement enforcement efforts. The dispute involved the U.S. party’s efforts to register and enforce a phrase that our clients deemed to be wholly descriptive and incapable of functioning as a mark. Based on investigative research and an aggressive inter partes proceeding lodged with the USPTO Trademark Trial and Appeal Board, AGG was able to swiftly secure a resolution in favor of our clients.
- Represented Israeli interests in their leasing and property management in the U.S.
- Represented Israeli-based prescription pharmaceutical companies with U.S.-related commercialization efforts, including reviewing promotional materials for compliance with FDA and Anti-Kickback laws.
- Represented Israeli-based over-the-counter drug and cosmetic companies with marketing efforts in the U.S. to ensure compliance with FDA requirements.
- Introduced numerous U.S. companies to the financial institutional market in Israel.
- Represented a foreign investor in structuring a joint venture for the $45 million acquisition of limited liability company interests pertaining to a commercial condominium in New York City.
- Represented an Israeli company on a $200 million credit facility.
- Drafted and provided FDA Regulatory Opinion Letters for Form F-1 Securities Filings for Israeli-based companies.
News & Insights
- PublicationsAGG Talks: Cross-Border Business Podcast2024 | Podcasts | Arnall Golden Gregory LLP
- EventsMeet AGG at IBA 2024 in Mexico CitySeptember 15-20, 2024 | Conferences | Mexico City
- EventsHenry Perlowski to Discuss How to Effectively Service Needs of Multi-Jurisdictional Clients During 2024 ELA Annual Global Membership ConferenceSeptember 11, 2024 | Speaking Engagements
- Alan G. Minsk
Partner
- Mindy S. Planer
Partner
- Abe J. Schear
Partner